Trials / Completed
CompletedNCT02916563
Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study
Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- LabStyle Innovations Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).
Detailed description
This study will be a non-randomized study conducted to assess the accuracy and performance of the Dario Blood Glucose Monitoring System at an elevated altitude. 50 subjects will be enrolled in this study. Participation includes a 15-20 minute visit to the clinical site where they will be consented. The participant will then receive a fingerstick to obtain capillary blood used to test the performance of the BGMS and to obtain a comparative glucose measurement on the reference method, the Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blood Glucose Monitoring System Altitude Performance | Performance as assessed against a reference method at an altitude of approximately 10,000 feet. |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-07-01
- Completion
- 2016-08-01
- First posted
- 2016-09-27
- Last updated
- 2020-11-19
- Results posted
- 2020-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02916563. Inclusion in this directory is not an endorsement.